Joshua Cressman Libbrecht Email & Phone Number

Paris, France, Fr

Paris, France, Fr

Paris, France, Fr

Sanofi purchased Bioverativ in 2018 and fully integrated in 2019.

Marketing Lead for ELOCTATEBioverativ was spun-off from Biogen in February 2017o Responsibilities and contributions across HCP, Patient and Payer Marketingo Results: 2017 Q3 YoY growth of >40%, >2,000 Hem A patients have chosen ELOCTATEo Enterprise commercial lead for FDA Consistent with Label Guidance. Brand lead for KOL Engagement (dev. 2018 plan)o Led HCP strategy & execution incl. campaign evolution; led Payer tactical execution for 1 year; led brand patient advocacy

Cambridge, Ma, Us

 Results: 2016 YoY growth of >66%; decreased spend by 30% without compromising message saturation Drove NPP plan that beat industry benchmarks while growing target list by 50%; created new NPP for unbranded asset Co-Led 2017 annual 3M plan; led 2016 HCP AOR RFP & transition; implemented patient engagement/retention program

Cambridge, Ma, Us

 Led team that identified commercial coverage for free drug patients that added >$50M in annual revenue Designed state-of-the-art patient financial assistance program; cycle time & cost reduction of >80% for medical benefits

Cambridge, Ma, Us

Led the development and implementation of the Patient Services program strategy for a phase III product (Plegridy)Key Knowledge, Skills & Experiences Gained: How to implement a medium scale cross-functional program (impacting 350 people), including gaining affiliate-wide buy-in; how to manage skilled workers that have more process knowledge than myself; Improved understanding of pharmaceutical channel and patient support service complexities.1) Managed a team of Program Leads, including hiring, providing opportunities for development, performance reviews and improving team morale. Results: 1 team member promoted upon program completion.2) Led program design, implementation, and evaluation ensuring cross-functional buy-in and that program innovations were within legal and regulatory guidelines.Results: 100% program readiness were ready to go by initial PDUFA date. This included the implementation of critical patient journey interventions, ensuring that the IT infrastructure - including analytics - was operationally ready as demonstrated during 2 mock launches, over 250 case managers trained, leading cross-functional internal and external stakeholders communications to ensure Plegridy's program pull-through. 3) Drove the identification of issues to Plegridy's launch success and lead cross-functional task forces Context: Issue was that launch products face delayed payer formulary reviews (ie, United Healthcare) and increased restrictions. To address this, I led the development of an innovative program called EnhancedPA, contracted with a 3rd party, piloted and implemented the program to assist with launch access hurdles. Results: The pilot outcome led to 3x faster PA approvals and 2x the positive PA outcomes, reducing cycle time and increasing the amount of commercial patients on Plegridy, Tecfidera and Avonex, and was rolled out to all Plegridy patients that used Patient Services upon launch.

The Woodlands, Tx, Us

• Drove marketplace analysis of corporate pipeline (Phase 2+) for VP Marketing, including competitive environment, product positioning, reimbursement, alliances/partnerships, worldwide revenue forecasts for ulcerative colitis & irritable bowel syndrome

Tokyo, Jp, Jp

Commercial advisory and decision support solutions for ADHD franchise- Created innovative and enhanced commercial performance analogue using financial industry techniques. Results provide better executive insight into trend direction, momentum and oscillation.

New York, New York, Us

Drove P&L success of 12 brands worth $80 million in 4 diverse therapeutic areas. All brands consistently over budget during tenure: 2012 204% to budget for portfolio, sales force quota >100% since 2010, +$41M increased revenue over budget since assuming role.Commecial lead for launch of taliglucerase alfa (elelyso) in Canada, and member of global launch team.Created and optimized multiple HCP/DTC Multichannel Marketing campaigns with ROI analyses; success balancing global campaign integration with local environment needs ($500k in expenses saved in 2012).Successfully led numerous cross-functional, matrix teams without direct authority → focused efforts on team engagement and co-creation to surpass expectations.Demonstrated strategic and tactical success throughout the product lifecycle: Launch (3 brands) --> Mature (9) --> LOE (2).Proactively initiated special projects - resulted in 2 product launches, 1 Canadian clinical trial and new cross-division patient assistance program.Example of Role Success:Xalatan: HCP/DTP MCM targeted non-personal promotional campaign combined with integrated sales messaging to provide unique value proposition to HCPs and consumers --> Results: nearly 50% brand retention 1.5 years post-LOE, 197% to budget.

New York, New York, Us

Market Research/Forecasting & Sales Planning/AdvisoryResponsible for 4 products’ primary & secondary research, focusing on customer insight identification and action plan developmentAchieved +/- 3% accuracy in product forecastsLed pre-launch research for Pfizer generics division (GenMed) → key driver of division’s mission, vision and value-offeringLiaison between Sales and Decision Support teams. Delivered bilingual presentations and customer meetings. Recommended numerous improvements for customer segmentation, routing and call planning, that were implemented in annual processes.Identified opportunities to enhance field force productivity → created and optimized CSO call plan for 3 brands ($125k savings)

New York, New York, Us

Secondary data responsibility for Oncology, Cardiovascular, Anti-Thrombotic/Bacteria/Fungal markets.Executive Dashboard business functionality responsibility; drove multiple software enhancements.Created a new doctor segmentation model leading to enhanced Field Force targeting.Key member of annual sales quota setting, customer targeting & segmentation processes.

New York, New York, Us

Conducted a competitive analysis of oncology advertising practices by industry competitors that provided directional insight and facilitated brand team’s decision-making.Delivered an environmental scan of a Phase III Oncology drug for pre-launch planning and KOL development.

Montreal, Quebec, Ca

ROI is a lead generation firm that provides specialized business development services to economic development organizations and private firms.Managed 6 direct reports; direct-line responsibility for performance of more than 20 contributors.Doubled corporate revenues in 1 year → developed Sales and Marketing team (3 sales representatives)Drove trade show lead generation strategy and execution: $400k in new ROI business in 2006International client and cross-cultural experience (China/India/Europe); completed over 60 government RFP’sManaged 3 teams that generated over 70% of company revenues in 2006

Mba, Marketing

Certificate In The Management Of Health Care Organizations, Health Care Management

Bachelor Of Commerce (B.Com.), Strategy, Human Resources